1 1933 157 ROLE OF YOGA IN MODIFYING CERTAIN CARDIOVASCULAR FUNCTIONS IN TYPE 2 DIABETIC PATIENTS. OBJECTIVES: 1. TO STUDY THE EFFECT OF FORTY DAYS OF YOGIC EXERCISES ON CARDIAC FUNCTIONS IN TYPE 2 DIABETICS. 2. TO STUDY THE EFFECT OF FORTY DAYS OF YOGIC EXERCISES ON BLOOD GLUCOSE LEVEL, GLYCOSYLATED HEMOGLOBIN. METHODS: THE PRESENT STUDY DONE IN TWENTY-FOUR TYPE 2 DM CASES PROVIDES METABOLIC AND CLINICAL EVIDENCE OF IMPROVEMENT IN GLYCAEMIC CONTROL AND AUTONOMIC FUNCTIONS. THESE MIDDLE-AGED SUBJECTS WERE TYPE II DIABETICS ON ANTIHYPERGLYCAEMIC AND DIETARY REGIMEN. THEIR BASELINE FASTING AND POSTPRANDIAL BLOOD GLUCOSE AND GLYCOSYLATED HB WERE MONITORED ALONG WITH AUTONOMIC FUNCTION STUDIES. THE EXPERT GAVE THESE PATIENTS TRAINING IN YOGA ASANAS AND THEY PURSUED THOSE 30-40 MIN/DAY FOR 40 DAYS UNDER GUIDANCE. THESE ASANAS CONSISTED OF 13 WELL KNOWN POSTURES, DONE IN A SEQUENCE. AFTER 40 DAYS OF YOGA ASANAS REGIMEN, THE PARAMETERS WERE REPEATED. RESULTS: THE RESULTS INDICATE THAT THERE WAS SIGNIFICANT DECREASE IN FASTING BLOOD GLUCOSE LEVELS FROM BASAL 190.08 +/- 18.54 IN MG/DL TO 141.5 +/- 16.3 IN MG/DL AFTER YOGA REGIMEN. THE POST PRANDIAL BLOOD GLUCOSE LEVELS DECREASED FROM 276.54 +/- 20.62 IN MG/DL TO 201.75 +/- 21.24 IN MG/DL, GLYCOSYLATED HEMOGLOBIN SHOWED A DECREASE FROM 9.03 +/- 0.29% TO 7.83 +/- 0.53% AFTER YOGA REGIMEN. THE PULSE RATE, SYSTOLIC AND DIASTOLIC BLOOD PRESSURE DECREASED SIGNIFICANTLY (FROM 86.45 +/- 2.0 TO 77.65 +/- 2.5 PULSE/MIN, FROM 142.0 +/- 3.9 TO 126.0 +/- 3.2 MM OF HG AND FROM 86.7 +/- 2.5 MM OF HG TO 75.5 +/- 2.1 MM OF HG AFTER YOGA REGIMEN RESPECTIVELY). CORRECTED QT INTERVAL (QTC) DECREASED FROM 0.42 +/- 0.0 TO 0.40 +/- 0.0. CONCLUSION: THESE FINDINGS SUGGEST THAT BETTER GLYCAEMIC CONTROL AND STABLE AUTONOMIC FUNCTIONS CAN BE OBTAINED IN TYPE 2 DM CASES WITH YOGA ASANAS AND PRANAYAMA. THE EXACT MECHANISM AS TO HOW THESE POSTURES AND CONTROLLED BREATHING INTERACT WITH SOMATO-NEURO-ENDOCRINE MECHANISM AFFECTING METABOLIC AND AUTONOMIC FUNCTIONS REMAINS TO BE WORKED OUT. 2004 2 2007 101 STUDY OF YOGA ASANAS IN ASSESSMENT OF PULMONARY FUNCTION IN NIDDM PATIENTS. CERTAIN YOGA ASANAS IF PRACTICED REGULARLY ARE KNOWN TO HAVE BENEFICIAL EFFECTS ON HUMAN BODY. THESE YOGA PRACTICES MIGHT BE INTERACTING WITH VARIOUS, SOMATO-NEURO-ENDOCRINE MECHANISMS TO HAVE THERAPEUTIC EFFECTS. THE PRESENT STUDY DONE IN TWENTY FOUR NIDDM PATIENTS OF 30 TO 60 YEAR OLD, PROVIDES METABOLIC AND CLINICAL EVIDENCE OF IMPROVEMENT IN GLYCAEMIC CONTROL AND PULMONARY FUNCTIONS. THESE MIDDLE-AGED SUBJECTS WERE TYPE II DIABETICS ON ANTIHYPERGLYCAEMIC AND DIETARY REGIMEN. THEIR BASELINE FASTING AND POSTPRANDIAL BLOOD GLUCOSE AND GLYCOSYLATED HB WERE MONITORED ALONG WITH PULMONARY FUNCTION STUDIES. THE EXPERT GAVE THESE PATIENTS TRAINING IN YOGA ASANAS AND WERE PURSED 30-40 MIN/DAY FOR 40 DAYS UNDER GUIDANCE. THESE ASANAS CONSISTED OF 13 WELL KNOWN POSTURES, DONE IN A SEQUENCE. AFTER 40 DAYS OF YOGA ASANAS REGIMEN, THE PARAMETERS WERE REPEATED. THE RESULTS INDICATE THAT THERE WAS SIGNIFICANT DECREASE IN FASTING BLOOD GLUCOSE LEVELS (BASAL 190.08 +/- 90.8 IN MG/DL TO 141.5 +/- 79.8 IN MG/DL). THE POSTPRANDIAL BLOOD GLUCOSE LEVELS ALSO DECREASED (276.54 +/- 101.0 IN MG/DL TO 201.75 +/- 104.1 IN MG/DL), GLYCOSYLATED HEMOGLOBIN SHOWED A DECREASE (9.03 +/- 1.4% TO 7.83 +/- 2.6%). THE FEV1, FVC, PEFR, MVV INCREASED SIGNIFICANTLY (1.81 +/- 0.4 LT TO 2.08 +/- 0.4 LT, 2.20 +/- 0.6 LT TO 2.37 +/- 0.5 LT, 3.30 +/- 1.0 LT/S TO 4.43 +/- 1.4 LT/S AND 64.59 +/- 25.7 LT MIN TO 76.28 +/- 28.1 LT/MIN RESPECTIVELY). FEV1/FVC% IMPROVED (85 +/- 0.2% TO 89 +/- 0.1%). THESE FINDINGS SUGGEST THAT BETTER GLYCAEMIC CONTROL AND PULMONARY FUNCTIONS CAN BE OBTAINED IN NIDDM CASES WITH YOGA ASANAS AND PRANAYAMA. THE EXACT MECHANISM AS TO HOW THESE POSTURES AND CONTROLLED BREATHING, INTERACT WITH SOMATO-NEURO-ENDOCRINE MECHANISM AFFECTING METABOLIC AND PULMONARY FUNCTIONS REMAINS TO BE WORKED OUT. 2002 3 1929 29 ROLE OF YOGA IN MANAGEMENT OF ESSENTIAL HYPERTENSION. TWENTY FIVE PATIENTS OF ESSENTIAL HYPERTENSION WERE STUDIED. OF THESE, 20 PATIENTS WERE NOT GIVEN ANY ANTIHYPERTENSIVE DRUG TREATMENT (GROUP A); OTHER 5 HAD TO BE PUT ON ANTIHYPERTENSIVE DRUGS BEFORE INCLUDING THEM IN THE STUDY (GROUP B). THESE PATIENTS WERE DEMONSTRATED "SHAVASANA" AND TRAINED TO PERFORM IT CORRECTLY. SHAVASANA THERAPY WAS CONTINUED FOR SIX MONTHS. THERE WAS A STATISTICALLY SIGNIFICANT FALL IN BOTH MEAN SYSTOLIC AND DIASTOLIC PRESSURE OF BOTH GROUPS. FURTHER, THERE WAS A SIGNIFICANT REDUCTION IN DOSES OF ANTIHYPERTENSIVE DRUGS, BEING GIVEN TO PATIENTS OF GROUP B. IN 65% PATIENTS OF GROUP A, BLOOD PRESSURE COULD BE CONTROLLED WITH SHAVASANA ONLY AND NO DRUG WAS NEEDED IN THEM AT ALL. BLOOD PRESSURE ROSE SIGNIFICANTLY TO PRE-SHAVASANA LEVELS IN PATIENTS WHO LEFT PRACTISING YOGA. THUS, WITH USE OF YOGA (SHAVASANA) IN THERAPY OF HYPERTENSION, REQUIREMENT OF ANTIHYPERTENSIVE DRUGS MAY BE SIGNIFICANTLY DECREASED AND IN SOME CASES MAY BE TOTALLY DISPENSED WITH AND IT MAY BE AN USEFUL ADJUNCT IN TREATMENT OF HYPERTENSION. 1984 4 2491 38 YOGA AS ANTIHYPERTENSIVE LIFESTYLE THERAPY: A SYSTEMATIC REVIEW AND META-ANALYSIS. OBJECTIVE: TO INVESTIGATE THE EFFICACY OF YOGA AS ANTIHYPERTENSIVE LIFESTYLE THERAPY AND IDENTIFY MODERATORS THAT ACCOUNT FOR VARIABILITY IN THE BLOOD PRESSURE (BP) RESPONSE TO YOGA. METHODS: WE SYSTEMATICALLY SEARCHED 6 ELECTRONIC DATABASES FROM INCEPTION THROUGH JUNE 4, 2018, FOR ARTICLES PUBLISHED IN ENGLISH LANGUAGE JOURNALS ON TRIALS OF YOGA INTERVENTIONS THAT INVOLVED ADULT PARTICIPANTS, REPORTED PREINTERVENTION AND POSTINTERVENTION BP, AND HAD A NONEXERCISE/NONDIET CONTROL GROUP. OUR SEARCH YIELDED 49 QUALIFYING CONTROLLED TRIALS (56 INTERVENTIONS). WE (1) EVALUATED THE RISK OF BIAS AND METHODOLOGICAL STUDY QUALITY, (2) PERFORMED META-REGRESSION ANALYSIS FOLLOWING RANDOM-EFFECTS ASSUMPTIONS, AND (3) GENERATED ADDITIVE MODELS THAT REPRESENTED THE LARGEST POSSIBLE CLINICALLY RELEVANT BP REDUCTIONS. RESULTS: ON AVERAGE, THE 3517 TRIAL PARTICIPANTS WERE MIDDLE-AGED (49.2+/-19.5 YEARS), OVERWEIGHT (27.9+/-3.6 KG/M(2)) ADULTS WITH HIGH BP (SYSTOLIC BP, 129.3+/-13.3 MM HG; DIASTOLIC BP, 80.7+/-8.4 MM HG). YOGA WAS PRACTICED 4.8+/-3.4 SESSIONS PER WEEK FOR 59.2+/-25.0 MINUTES PER SESSION FOR 13.2+/-7.5 WEEKS. ON AVERAGE, YOGA ELICITED MODERATE REDUCTIONS IN SYSTOLIC BP (WEIGHTED MEAN EFFECT SIZE, -0.47; 95% CI, -0.62-0.32, -5.0 MM HG) AND DIASTOLIC BP (WEIGHTED MEAN EFFECT SIZE, -0.47; 95% CI, -0.61 TO -0.32; -3.9 MM HG) COMPARED WITH CONTROLS (P<.001 FOR BOTH SYSTOLIC BP AND DIASTOLIC BP). CONTROLLING FOR PUBLICATION BIAS AND METHODOLOGICAL STUDY QUALITY, WHEN YOGA WAS PRACTICED 3 SESSIONS PER WEEK AMONG SAMPLES WITH HYPERTENSION, YOGA INTERVENTIONS THAT INCLUDED BREATHING TECHNIQUES AND MEDITATION/MENTAL RELAXATION ELICITED BP REDUCTIONS OF 11/6 MM HG COMPARED WITH THOSE THAT DID NOT (IE, 6/3 MM HG). CONCLUSION: OUR RESULTS INDICATE THAT YOGA IS A VIABLE ANTIHYPERTENSIVE LIFESTYLE THERAPY THAT PRODUCES THE GREATEST BP BENEFITS WHEN BREATHING TECHNIQUES AND MEDITATION/MENTAL RELAXATION ARE INCLUDED. 2019 5 31 12 12-MONTH FOLLOW-UP OF YOGA AND BIO-FEEDBACK IN THE MANAGEMENT OF HYPERTENSION. TWENTY HYPERTENSIVE PATIENTS TREATED BY PSYCHOPHYSICAL RELAXATION EXERCISES WERE FOLLOWED UP MONTHLY FOR 12 MONTHS. AGE AND SEX MATCHED HYPERTENSIVE CONTROLS WERE SIMILARLY FOLLOWED UP FOR 9 MONTHS. STATISTICALLY SIGNIFICANT REDUCTIONS IN BLOOD-PRESSURE (BP) AND ANTIHYPERTENSIVE DRUG REQUIREMENTS WERE SATISFACTORILY MAINTAINED IN THE TREATMENT GROUP. MERE REPETITION OF B.P. MEASUREMENTS AND INCREASED MEDICAL ATTENTION DID NOT IN THEMSELVES REDUCE B.P. SIGNIFICANTLY IN CONTROL PATIENTS. 1975 6 274 35 ADDITIONAL BENEFIT OF YOGA TO STANDARD LIFESTYLE MODIFICATION ON BLOOD PRESSURE IN PREHYPERTENSIVE SUBJECTS: A RANDOMIZED CONTROLLED STUDY. HIGH BLOOD PRESSURE (BP) IS A KNOWN RISK FACTOR FOR CARDIOVASCULAR DISEASE MORBIDITY. CONSIDERING THE GROWING EVIDENCE OF NONPHARMACOLOGICAL INTERVENTIONS IN THE MANAGEMENT OF HIGH BP, WE DESIGNED A RANDOMIZED, PARALLEL ACTIVE-CONTROLLED STUDY ON THE EFFECT OF YOGA AND STANDARD LIFESTYLE MODIFICATION (LSM) ON BP AND HEART RATE IN INDIVIDUALS WITH PREHYPERTENSION (SYSTOLIC BP 120-139 MM HG AND/OR DIASTOLIC BP 80-89 MM HG). VOLUNTEERS (20-60 YEARS) OF BOTH GENDERS WITHOUT ANY KNOWN CARDIOVASCULAR DISEASE WERE RANDOMIZED INTO EITHER LSM GROUP (N = 92) OR LSM+YOGA GROUP (N = 92). BEFORE THE INTERVENTION, AGE, WAIST CIRCUMFERENCE, PHYSICAL ACTIVITY, BP AND FASTING PLASMA GLUCOSE AND LIPIDS WERE COMPARABLE BETWEEN THE GROUPS. AFTER 12 WEEKS OF INTERVENTION, WE OBSERVED A SIGNIFICANT REDUCTION IN THE BP AND HEART RATE IN BOTH THE GROUPS. FURTHER, THE REDUCTION IN SYSTOLIC BP WAS SIGNIFICANTLY MORE IN LSM+YOGA GROUP (6 MM HG) AS COMPARED WITH LSM GROUP (4 MM HG). IN ADDITION, 13 PREHYPERTENSIVES BECAME NORMOTENSIVES IN LSM+YOGA GROUP AND FOUR IN LSM GROUP. THE RESULTS INDICATE EFFICACY OF NONPHARMACOLOGICAL INTERVENTION AND THE ADDITIONAL BENEFIT OF YOGA TO STANDARD LSM. FURTHER RESEARCH IN THIS FIELD MAY ADD TO THE LEVEL OF EVIDENCE ON THE BENEFIT OF YOGA, IN THE REDUCTION OF BP IN HIGH BP SUBJECTS, IN THE SCIENTIFIC LITERATURE. 2015 7 221 34 A SYSTEMATIC REVIEW AND META-ANALYSIS OF YOGA FOR HYPERTENSION. BACKGROUND: THE AIM OF THIS SYSTEMATIC REVIEW AND META-ANALYSIS WAS TO EVALUATE THE QUALITY OF EVIDENCE AND THE STRENGTH OF RECOMMENDATION FOR YOGA AS A THERAPEUTIC MEANS IN THE MANAGEMENT OF PREHYPERTENSION AND HYPERTENSION. METHODS: MEDLINE/PUBMED, SCOPUS, CENTRAL, AND INDMED WERE SCREENED THROUGH FEBRUARY 2014 FOR RANDOMIZED CONTROLLED TRIALS (RCTS) ON THE EFFECTS OF YOGA INTERVENTIONS (>/=8 WEEKS) COMPARED WITH USUAL CARE OR ANY ACTIVE CONTROL INTERVENTION ON BLOOD PRESSURE IN PATIENTS WITH PREHYPERTENSION (120-139/80-89 MM HG) OR HYPERTENSION (>/=140/>/=90 MM HG). RISK OF BIAS WAS ASSESSED USING THE COCHRANE RISK OF BIAS TOOL; QUALITY OF EVIDENCE WAS ASSESSED ACCORDING TO THE GRADE RECOMMENDATIONS. RESULTS: SEVEN RCTS WITH A TOTAL OF 452 PATIENTS WERE INCLUDED. COMPARED WITH USUAL CARE, VERY LOW-QUALITY EVIDENCE WAS FOUND FOR EFFECTS OF YOGA ON SYSTOLIC (6 RCTS, N = 278; MEAN DIFFERENCE (MD) = -9.65 MM HG, 95% CONFIDENCE INTERVAL (CI) = -17.23 TO -2.06, P = 0.01; HETEROGENEITY: I (2) = 90%, CHI(2) = 48.21, P < 0.01) AND DIASTOLIC BLOOD PRESSURE (6 RCTS, N = 278; MD = -7.22 MM HG, 95% CI = -12.83 TO -1.62, P = 0.01; HETEROGENEITY: I (2) = 92%, CHI(2) = 64.84, P < 0.01). SUBGROUP ANALYSES REVEALED EFFECTS FOR RCTS THAT INCLUDED HYPERTENSIVE PATIENTS BUT NOT FOR RCTS THAT INCLUDED BOTH HYPERTENSIVE AND PREHYPERTENSIVE PATIENTS, AS WELL AS FOR RCTS THAT ALLOWED ANTIHYPERTENSIVE COMEDICATION BUT NOT FOR THOSE THAT DID NOT. MORE ADVERSE EVENTS OCCURRED DURING YOGA THAN DURING USUAL CARE. COMPARED WITH EXERCISE, NO EVIDENCE WAS FOUND FOR EFFECTS OF YOGA ON SYSTOLIC OR DIASTOLIC BLOOD PRESSURE. CONCLUSIONS: LARGER STUDIES ARE REQUIRED TO CONFIRM THE EMERGING BUT LOW-QUALITY EVIDENCE THAT YOGA MAY BE A USEFUL ADJUNCT INTERVENTION IN THE MANAGEMENT OF HYPERTENSION. 2014 8 328 33 ANTIHYPERTENSIVE EFFECTS OF YOGA IN A GENERAL PATIENT POPULATION: REAL-WORLD EVIDENCE FROM ELECTRONIC HEALTH RECORDS, A RETROSPECTIVE CASE-CONTROL STUDY. BACKGROUND: DESPITE DECADES OF RESEARCH AND ESTABLISHED TREATMENT STRATEGIES, HYPERTENSION REMAINS A PREVALENT AND INTRACTABLE PROBLEM AT THE POPULATION LEVEL. YOGA, A LIFESTYLE-BASED PRACTICE, HAS DEMONSTRATED ANTIHYPERTENSIVE EFFECTS IN CLINICAL TRIAL SETTINGS, BUT LITTLE IS KNOWN ABOUT ITS EFFECTIVENESS IN THE REAL WORLD. HERE, WE USE ELECTRONIC HEALTH RECORDS TO INVESTIGATE THE ANTIHYPERTENSIVE EFFECTS OF YOGA AS USED BY PATIENTS IN THEIR DAILY LIVES. METHODS: A RETROSPECTIVE, OBSERVATIONAL CASE-CONTROL STUDY OF 1815 RECORDS AMONG 1355 YOGA EXPOSED PATIENTS AND 40,326 RECORDS AMONG 8682 YOGA NON-EXPOSED PATIENTS COLLECTED BETWEEN 2006 AND 2016 FROM A REGIONAL ACADEMIC HEALTH SYSTEM. LINEAR MIXED-EFFECTS MODELS WERE USED TO ESTIMATE THE AVERAGE TREATMENT EFFECT OF YOGA ON SYSTOLIC AND DIASTOLIC BLOOD PRESSURES. MIXED EFFECTS LOGISTIC REGRESSION MODELS WERE USED TO CALCULATE ODDS RATIOS FOR YOGA USE AND FOUR BLOOD PRESSURE CATEGORIES: NORMAL, ELEVATED, STAGE I, AND STAGE II HYPERTENSION. RESULTS: YOGA PATIENTS ARE PREDOMINANTLY WHITE (88.0%) AND FEMALE (87.8%) WITH MEDIAN AGE 46 YEARS (IQR 32-57) WHO USE YOGA ONE TIME PER WEEK (62.3%). YOGA IS ASSOCIATED WITH LOWER SYSTOLIC (- 2.8 MMHG, STANDARD ERROR 0.6; P < .001) AND DIASTOLIC (- 1.5 MMHG, STANDARD ERROR 0.5; P = 0.001) BLOOD PRESSURES. PATIENTS USING YOGA HAVE 85% INCREASED ODDS (OR 1.85, 95% CI 1.39-2.46) OF HAVING NORMAL BLOOD PRESSURE RELATIVE TO YOGA NON-EXPOSED PATIENTS. PATIENTS AGED 40-59 YEARS HAVE 67% DECREASED ODDS (0.33, 95% CI 0.14-0.75) OF HAVING STAGE II HYPERTENSION. ALL EFFECT SIZES ARE AGE-DEPENDENT. CONCLUSIONS: YOGA, AS USED BY PATIENTS IN THEIR DAILY LIVES, MAY BE AN EFFECTIVE STRATEGY FOR BLOOD PRESSURE CONTROL AND THE PREVENTION OF HYPERTENSION AT THE POPULATION LEVEL. 2022 9 1973 32 SHOULD ACUPUNCTURE, BIOFEEDBACK, MASSAGE, QI GONG, RELAXATION THERAPY, DEVICE-GUIDED BREATHING, YOGA AND TAI CHI BE USED TO REDUCE BLOOD PRESSURE?: RECOMMENDATIONS BASED ON HIGH-QUALITY SYSTEMATIC REVIEWS. BACKGROUND: THIS REVIEW AIMS TO RATE THE QUALITY OF EVIDENCE AND THE STRENGTH OF RECOMMENDATIONS IN HIGH-QUALITY SYSTEMATIC REVIEWS OF NON-DRUG THERAPIES. HYPERTENSIVE PATIENTS WHO ARE RESISTANT OR NON-ADHERENT TO ANTIHYPERTENSIVE DRUGS MAY BE EASIER TO MANAGE IF THEY CHOOSE ALTERNATIVE NON-DRUG THERAPIES FOR HYPERTENSION, BASED ON THIS REVIEW. METHODS: P: ADULTS (>18 YEARS), EXCEPT PREGNANT WOMEN, WITH ESSENTIAL HYPERTENSION. I: CUPPING, MOXIBUSTION, ACUPUNCTURE, ACUPOINT STIMULATION, YOGA, MEDITATION, TAI CHI, QI GONG, CHINESE MASSAGE, MASSAGE, SPINAL MANIPULATION, BIOFEEDBACK, DEVICE-GUIDED BREATHING THERAPY, AROMATHERAPY, MUSIC THERAPY, AND RELAXATION APPROACHES. C: 1. NO TREATMENT. 2. SHAM THERAPY. 3. CONVENTIONAL TREATMENT, INCLUDING ANTIHYPERTENSIVE DRUGS AND LIFESTYLE MODIFICATION (E.G., EXERCISE). O: 1. CHANGE IN THE INCIDENCE OF CARDIOVASCULAR DEATH. 2. CHANGE IN THE INCIDENCE OF MYOCARDIAL INFARCTION. 3. CHANGE IN THE INCIDENCE OF STROKE. 4. CHANGE IN BLOOD PRESSURE (BP). 5. EFFICACY RATE OF BP LOWERING. 6. ADVERSE EFFECTS (REVIEW SPECIFIC). S: SYSTEMATIC REVIEWS OF RANDOMIZED CONTROLLED TRIALS, INCLUDING META-ANALYSES AND ASSESSMENTS OF THE METHODOLOGICAL QUALITY/RISK OF BIAS. INFORMATION SOURCES: COCHRANE DATABASE OF SYSTEMATIC REVIEWS, DATABASE OF ABSTRACTS OF REVIEWS OF EFFECTS, COCHRANE LIBRARY, PUBMED, WEB OF SCIENCE, CHINA NATIONAL KNOWLEDGE INFRASTRUCTURE, AND CHINESE SCIENTIFIC JOURNAL DATABASE WERE SEARCHED. THE BIBLIOGRAPHIES OF THE INCLUDED ARTICLES WERE ALSO SEARCHED FOR RELEVANT SYSTEMATIC REVIEWS. GRADE CRITERIA WERE USED TO RATE THE QUALITY OF EVIDENCE IN SYSTEMATIC REVIEWS CONSIDERING 6 FACTORS, INCLUDING RISK OF BIAS. RESULTS: THIS REVIEW ULTIMATELY INCLUDED 13 SYSTEMATIC REVIEWS OF 14 NON-DRUG THERAPIES (ACUPUNCTURE, WET CUPPING, BADUANJIN, BLOOD LETTING, AURICULAR ACUPUNCTURE, MUSIC, MASSAGE, QI GONG, MOXIBUSTION, RELAXATION THERAPIES, BIOFEEDBACK, DEVICE-GUIDED BREATHING, YOGA AND TAI CHI) BASED ON THE INCLUSION CRITERIA. THE QUALITY OF EVIDENCE WAS GENERALLY LOW, AND WEAK RECOMMENDATIONS WERE GIVEN FOR MOST THERAPIES EXCEPT MASSAGE AND ACUPUNCTURE PLUS ANTIHYPERTENSIVE DRUG. BASED ON THE ANALYZED EVIDENCE, MASSAGE AND ACUPUNCTURE PLUS ANTIHYPERTENSIVE DRUG COULD BENEFIT PEOPLE WHO WANT TO LOWER THEIR BP AND DO NOT HAVE CONTRAINDICATIONS FOR MASSAGE AND ACUPUNCTURE PLUS ANTIHYPERTENSIVE DRUG. DISCUSSION/STRENGTH: THE GRADE APPROACH MAKES THIS REVIEW A UNIQUE REFERENCE FOR PEOPLE WHO ARE CONSIDERING THE GRADE OF QUALITY OF EVIDENCE IN SYSTEMATIC REVIEWS, THE BALANCE OF DESIRABLE AND UNDESIRABLE CONSEQUENCES AND THE STRENGTH OF RECOMMENDATIONS TO DECIDE WHICH INTERVENTION SHOULD BE USED TO REDUCE BP. LIMITATIONS: MANY NON-DRUG THERAPIES WERE EXCLUDED DUE TO THE LOW METHODOLOGICAL QUALITY OF THEIR SYSTEMATIC REVIEWS, AND ONLY 14 THERAPIES WERE EVALUATED IN THIS REVIEW. AS NO PATIENT-IMPORTANT OUTCOMES WERE REVIEWED, SURROGATE OUTCOMES WERE USED TO RATE THE STRENGTH OF RECOMMENDATIONS. THIS APPROACH MAY CAUSE A DECREASE IN EVIDENCE QUALITY ACCORDING TO GRADE, BUT WE ARGUE THAT THIS IS APPROPRIATE IN THE CONTEXT OF THIS REVIEW. 2019 10 1915 33 ROLE OF NATUROPATHY AND YOGA TREATMENT IN THE MANAGEMENT OF HYPERTENSION. AIM: THE PRIMARY AIM WAS TO STUDY THE EFFECT OF NATUROPATHY AND YOGA INTERVENTIONS IN TREATMENT OF MILD TO MODERATE HYPERTENSION. DESIGN: THE VARIABLES OF INTEREST WERE MEASURED AT THE BEGINNING AND END OF THE INTERVENTION USING A PRE-POST DESIGN. SETTING: THE STUDY WAS CONDUCTED BY INYS MEDICAL RESEARCH SOCIETY IN JINDAL NATURE CURE INSTITUTE, BANGALORE. SUBJECTS: A TOTAL OF 104 SUBJECTS, ALREADY DIAGNOSED WITH MILD TO MODERATE HYPERTENSION AND ON TREATMENT WITH ANTIHYPERTENSIVE MEDICINES WERE INCLUDED IN STUDY. INTERVENTIONS: THE INTERVENTION CONSISTED OF VARIOUS INPATIENT ADMINISTRATION OF DIFFERENT NATUROPATHY TREATMENTS, YOGA THERAPIES, LOW CALORIE AND LOW SODIUM DIET FOR 21 DAYS. ANTIHYPERTENSIVE MEDICINES WERE WITHDRAWN FOR SOME PATIENTS IN ONE WEEK BASED UPON RESPONSE TO THE TREATMENT. OUTCOME MEASURES: THE OUTCOME MEASURES WERE VALUES OF DIASTOLIC AND SYSTOLIC BLOOD PRESSURE AND BODY WEIGHT. SUBJECTS WERE FOLLOWED FOR A PERIOD OF ONE YEAR AFTER EVERY 3 MONTHS. RESULTS: AFTER STARTING NONPHARMACOLOGICAL APPROACH OF NATUROPATHY AND YOGA, SYSTOLIC BLOOD PRESSURE CAME DOWN FROM MEAN OF 139.6 TO 129.6 WHERE AS IT CAME DOWN FROM 91.2 TO 86.1 FOR DIASTOLIC BLOOD PRESSURE. AT THE SAME TIME FAVORABLE EFFECT WAS ALSO SEEN IN OTHER VARIABLES LIKE LIPID PROFILE AND BODY WEIGHT. AT THE END OF ONE YEAR OUT OF 57 PATIENTS WHO CAME FOR FOLLOW-UP, 14 CASES WERE FOUND TO HAVE BLOOD PRESSURE WITHIN NORMAL RANGES WITHOUT ANY MEDICATION OVER THE PREVIOUS 12 MONTHS. CONCLUSION: NATUROPATHY AND YOGA THERAPY CAN BE CONSIDERED AS A VALUABLE NONPHARMACOLOGICAL APPROACH IN TREATMENT OF HYPERTENSION. 2011 11 2213 27 THE HYPOTENSIVE EFFECT OF YOGA'S BREATHING EXERCISES: A SYSTEMATIC REVIEW. THE AIM OF THIS REVIEW WAS TO EVALUATE THE EFFECT OF PRANAYAMA (YOGA'S BREATHING EXERCISES) ON BP AND ITS APPLICABILITY IN THE TREATMENT OF HYPERTENSION. THIRTEEN TRIALS, ASSESSING ACUTE (EIGHT STUDIES) AND CHRONIC (FIVE STUDIES) BP RESPONSE TO PRANAYAMA WERE INCLUDED. SIGNIFICANT BP REDUCTIONS AFTER PRANAYAMA WERE FOUND IN BOTH ACUTE (2-10 MMHG MEAN SBP REDUCTION, N = 5 STUDIES; 1 MMHG MEAN DBP REDUCTION, N = 1 STUDY) AND CHRONIC STUDIES (4-21 MMHG MEAN SBP REDUCTION, N = 3 STUDIES; 4-7 MMHG MEAN DBP REDUCTION, N = 2 STUDIES). THE PRANAYAMA'S EFFECT ON BP WERE NOT ROBUST AGAINST SELECTION BIAS DUE TO THE LOW QUALITY OF STUDIES. BUT, THE LOWERING BP EFFECT OF PRANAYAMA IS ENCOURAGING. THE PRANAYAMA WITH SLOWER RHYTHMS AND MANIPULATION OF THE NOSTRILS, MAINLY WITH BREATHS BY THE LEFT, PRESENT BETTER RESULTS WHEN COMPARED WITH THE OTHER TYPES AND SHOULD BE THE MAIN PRANAYAMA APPLIED WHEN THE GOAL IS TO REDUCE BLOOD PRESSURE ESPECIALLY IN HYPERTENSIVE PATIENTS. 2017 12 1402 43 IMPACT OF YOGA ON BLOOD PRESSURE AND QUALITY OF LIFE IN PATIENTS WITH HYPERTENSION - A CONTROLLED TRIAL IN PRIMARY CARE, MATCHED FOR SYSTOLIC BLOOD PRESSURE. BACKGROUND: MEDICAL TREATMENT OF HYPERTENSION IS NOT ALWAYS SUFFICIENT TO ACHIEVE BLOOD PRESSURE CONTROL. DESPITE THIS, PREVIOUS STUDIES ON SUPPLEMENTARY THERAPIES, SUCH AS YOGA, ARE RELATIVELY FEW. WE INVESTIGATED THE EFFECTS OF TWO YOGA INTERVENTIONS ON BLOOD PRESSURE AND QUALITY OF LIFE IN PATIENTS IN PRIMARY HEALTH CARE DIAGNOSED WITH HYPERTENSION. METHODS: ADULT PATIENTS (AGE 20-80 YEARS) WITH DIAGNOSED HYPERTENSION WERE IDENTIFIED BY AN ELECTRONIC CHART SEARCH AT A PRIMARY HEALTH CARE CENTER IN SOUTHERN SWEDEN. IN TOTAL, 83 SUBJECTS WITH BLOOD PRESSURE VALUES OF 120-179/ 0.1). THE PATTERN OF CHANGE IN MOST OF THE STUDY PARAMETERS WAS SUCH THAT VALUES ABOVE NORMAL RANGE WERE LOWERED BUT VALUES WITHIN NORMAL RANGE WERE UNALTERED. THE ACTION OF YOGA ON DIASTOLIC BLOOD PRESSURE, MALONDIALDEHYDE ADDUCTS AND KIDNEY FUNCTION IN HYPERTENSIVES WAS OF COUNTERACTIVE NATURE AND FELT TO BE DISTINCTLY DIFFERENT THAN THE EFFECT OF DRUGS. 2011 16 763 25 EFFECT OF TELEREHABILITATION ON LONG-TERM ADHERENCE TO YOGA AS AN ANTIHYPERTENSIVE LIFESTYLE INTERVENTION: RESULTS OF A RANDOMIZED CONTROLLED TRIAL. BACKGROUND: AND PURPOSE: WE AIMED TO INVESTIGATE THE ADHERENCE TO YOGA AS AN ANTIHYPERTENSIVE INTERVENTION THROUGH TELEREHABILITATION. MATERIALS AND METHODS: IN A RANDOMIZED CONTROLLED TRIAL PATIENTS WERE CONSECUTIVELY ENROLLED AND RANDOMLY ASSIGNED TO INTERVENTION OR CONTROL GROUP. BOTH GROUPS RECEIVED STANDARDIZED YOGA TRAINING DURING THREE WEEKS OF INPATIENT REHABILITATION. THE INTERVENTION GROUP RECEIVED TELEREHABILITATION AFTER DISCHARGE; THE CONTROL GROUP RECEIVED THE USUAL CARE. DATA WAS COLLECTED AT ADMISSION (T1), DISCHARGE (T2) AND AT FOLLOW UP AFTER SIX (T3) AND 12 MONTHS (T4). THE PRIMARY ENDPOINT WAS FOLLOW-UP ADHERENCE ASSESSED IN AN INTENTION-TO-TREAT ANALYSIS. RESULTS: 228 MALE REHABILITATION PATIENTS (MEAN AGE 53.3+/-5.8 YEARS, MEAN BLOOD PRESSURE 139.5+/-10.2/ 86.7+/-8.0MMHG) THE INTERVENTION RESULTED IN SIGNIFICANTLY INCREASED ADHERENCE COMPARED TO CONTROL GROUP (T3: 40.0% VS. 19.5%, P=0.001; T4: 36.5% VS. 23.9%, P=0.038); BLOOD PRESSURE AND QUALITY OF LIFE IMPROVED. CONCLUSION: TELEREHABILITATION SIGNIFICANTLY IMPROVES YOGA ADHERENCE MAINTAINING ACHIEVED HEALTH BENEFITS IN THE LONG TERM. 2019 17 811 34 EFFECT OF YOGA ON BLOOD PRESSURE IN PREHYPERTENSION: A SYSTEMATIC REVIEW AND META-ANALYSIS. INTRODUCTION: PREHYPERTENSION IS A PRECURSOR FOR DEVELOPING HYPERTENSION AND IS A RISK FACTOR FOR CARDIOVASCULAR DISEASES. YOGA THERAPY MAY HAVE A ROLE IN LOWERING THE BLOOD PRESSURES IN PREHYPERTENSION AND HYPERTENSION. THIS SYSTEMATIC REVIEW AIMS TO SYNTHESIZE THE AVAILABLE LITERATURE FOR THE SAME. METHODOLOGY. DATABASES SUCH AS PUBMED, EMBASE, SCOPUS, AND WEB OF SCIENCE WERE SEARCHED FOR RANDOMISED CONTROL TRIALS ONLY IN THE TIME DURATION OF 2010-2021. THE MAIN OUTCOME OF INTEREST WAS SYSTOLIC AND DIASTOLIC BLOOD PRESSURES. ARTICLES WERE SCREENED BASED ON THE INCLUSION CRITERIA, AND 8 ARTICLES WERE RECRUITED FOR THE REVIEW. META-ANALYSIS WAS DONE FOR SUITABLE ARTICLES. REVMAN 5.4 BY COCHRANE WAS USED FOR META-ANALYSIS AND FOREST PLOT CONSTRUCTION. RISK OF BIAS WAS DETERMINED USING THE DOWNS AND BLACK CHECKLIST BY THREE INDEPENDENT AUTHORS. RESULTS: THE META-ANALYSIS OF THE ARTICLES FAVOURED YOGA INTERVENTION OVER THE CONTROL INTERVENTION. YOGA THERAPY HAD SIGNIFICANTLY REDUCED THE SYSTOLIC PRESSURE (-0.62 STANDARD MEAN DIFFERENCE, AT IV FIXED 95% CI: -0.83, -0.41) AND DIASTOLIC PRESSURE (-0.81 STANDARD MEAN DIFFERENCE, AT IV RANDOM 95% CI: -1.39, -0.22). SECONDARY OUTCOME MEASURES STUDIED WERE HEART RATE, WEIGHT, BMI, WAIST CIRCUMFERENCE, AND LIPID PROFILE. THE MAIN PROTOCOL OF YOGA THERAPY INCLUDED POSTURES, BREATHING EXERCISES, AND DIFFERENT MEDITATION TECHNIQUES. A SIGNIFICANT REDUCTION IN SECONDARY OUTCOMES WAS OBSERVED, EXCEPT FOR HDL VALUES IN LIPID PROFILE WHICH SHOWED A GRADUAL INCREASE IN YOGA GROUP IN COMPARISON WITH ALTERNATIVE THERAPY. CONCLUSION: YOGA THERAPY HAS SHOWN TO BE SIGNIFICANT IN THE REDUCTION OF SYSTOLIC AND DIASTOLIC PRESSURE IN PREHYPERTENSIVE POPULATION. SUPPORTING EVIDENCE LACKS IN PROVIDING A PROPER STRUCTURED DOSAGE OF YOGA ASANAS AND BREATHING TECHNIQUES. CONSIDERING THE EXISTING LITERATURE AND EVIDENCE, YOGA THERAPY CAN BE USED AND RECOMMENDED IN PREHYPERTENSIVE POPULATION AND CAN BE BENEFICIAL IN REDUCING THE CHANCES OF DEVELOPING HYPERTENSION OR CARDIOVASCULAR DISEASES. 2021 18 1374 44 IMPACT OF AN INTEGRATED YOGA THERAPY PROTOCOL ON INSULIN RESISTANCE AND GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. OBJECTIVE: DIABETES MELLITUS (DM), CHARACTERIZED BY CHRONIC HYPERGLYCEMIA, IS ATTRIBUTED TO RELATIVE INSULIN DEFICIENCY OR RESISTANCE, OR BOTH. STUDIES HAVE SHOWN THAT YOGA CAN MODULATE PARAMETERS OF INSULIN RESISTANCE. THE PRESENT STUDY EXPLORED THE POSSIBLE BENEFICIAL EFFECTS OF INTEGRATED YOGA THERAPY WITH REFERENCE TO GLYCEMIC CONTROL AND INSULIN RESISTANCE (IR) IN INDIVIDUALS WITH DIABETES MAINTAINED ON STANDARD ORAL MEDICAL CARE WITH YOGA THERAPY, COMPARED TO THOSE ON STANDARD ORAL MEDICAL CARE ALONE. METHODS: IN THIS STUDY, THE SUBJECTS ON YOGA INTERVENTION COMPRISED 35 TYPE 2 DIABETICS, AND AN EQUAL NUMBER OF VOLUNTEERS CONSTITUTED THE CONTROL GROUP. SUBJECTS RANGED IN AGE FROM 30 TO 70 YEARS, WITH HEMOGLOBIN A1C (HBA1C) TEST MORE THAN 7%, AND WERE MAINTAINED ON DIABETIC DIET AND ORAL HYPOGLYCEMIC AGENTS. BLOOD SAMPLES WERE DRAWN PRIOR TO AND AFTER 120 DAYS OF INTEGRATED YOGA THERAPY INTERVENTION. FASTING BLOOD GLUCOSE (FBG), POST-PRANDIAL BLOOD GLUCOSE (PPBG), HBA1C, INSULIN, AND LIPID PROFILE WERE ASSESSED IN BOTH THE INTERVENTION AND CONTROL GROUPS. RESULTS: THE INTERVENTION GROUP REVEALED SIGNIFICANT IMPROVEMENTS IN BODY MASS INDEX (BMI) (0.7 KG/M(2) MEDIAN DECREASE; P=0.001), FBG (20 MG/DL MEDIAN DECREASE; P<0.001), PPBG (33 MG/DL MEDIAN DECREASE; P<0.001), HBA1C (0.4% MEDIAN DECREASE; P<0.001), HOMEOSTATIC MODEL ASSESSMENT FOR INSULIN RESISTANCE (HOMA-IR) (1.2 MEDIAN DECREASE; P<0.001), CHOLESTEROL (13 MG/DL MEDIAN DECREASE, P=0.006), TRIACYLGLYCEROL (22 MG/DL MEDIAN DECREASE; P=0.027), LOW-DENSITY LIPOPROTEIN (6 MG/DL MEDIAN DECREASE; P=0.004), AND VERY-LOW-DENSITY LIPOPROTEIN LEVELS (4 MG/DL MEDIAN DECREASE; P=0.032). INCREASES IN HIGH-DENSITY LIPOPROTEIN AFTER 120 DAYS WERE NOT SIGNIFICANT (6 MG/DL MEDIAN INCREASE; P=0.15). HOWEVER, WHEN COMPARED TO CHANGES OBSERVED IN PATIENTS IN THE CONTROL GROUP, ALL THESE IMPROVEMENTS PROVED TO BE SIGNIFICANT. CONCLUSION: ADMINISTRATION OF INTEGRATED YOGA THERAPY TO INDIVIDUALS WITH DIABETES LEADS TO A SIGNIFICANT IMPROVEMENT IN GLYCEMIC CONTROL, INSULIN RESISTANCE, AND KEY BIOCHEMICAL PARAMETERS. 2022 19 953 33 EFFECTS OF A HEALTH WORKER-LED 3-MONTH YOGA INTERVENTION ON BLOOD PRESSURE OF HYPERTENSIVE PATIENTS: A RANDOMISED CONTROLLED MULTICENTRE TRIAL IN THE PRIMARY CARE SETTING. BACKGROUND: HYPERTENSION CONTROL REMAINS A MAJOR CHALLENGE GLOBALLY. A RECENT SYSTEMATIC REVIEW SUGGESTED THAT YOGA HAS BENEFICIAL EFFECTS ON REDUCING BLOOD PRESSURE. HOWEVER, THE ROLE OF YOGA IN HYPERTENSION MANAGEMENT IN PRIMARY HEALTH CARE HAS RECEIVED LITTLE ATTENTION, AND NO STUDIES HAVE EVALUATED THE IMPACT OF A YOGA PROGRAM FULLY DELIVERED BY HEALTH CARE STAFF ON HYPERTENSION. THIS STUDY, THEREFORE, ASSESSED THE EFFECTS OF A HEALTH WORKER-LED YOGA INTERVENTION ON BLOOD PRESSURE REDUCTION AMONG HYPERTENSIVES PATIENTS IN THE PRIMARY CARE SETTING. METHODS: THIS WAS A MULTICENTRIC, TWO-ARM, RANDOMISED TRIAL CONDUCTED AMONG HYPERTENSIVE PATIENTS IN SEVEN AYURVEDA HEALTH CENTRES IN NEPAL BETWEEN MARCH 2017 AND JUNE 2018. ONE HUNDRED AND TWENTY-ONE PARTICIPANTS WHO WERE ON OR WITHOUT MEDICATIONS WERE RANDOMISED TO INTERVENTION (N = 61) AND WAIT-LIST CONTROL (N = 60) GROUPS USING STRATIFIED BLOCK RANDOMISATION. PARTICIPANTS IN THE INTERVENTION ARM RECEIVED AN INTERVENTION CONSISTING OF AN INITIAL FIVE-DAY STRUCTURED YOGA TRAINING AT THE CENTRES AND THEN A FURTHER HOME-BASED PRACTICE OF YOGA FOR FIVE DAYS A WEEK FOR THE FOLLOWING 90 DAYS. BOTH INTERVENTION AND CONTROL GROUPS ALSO PARTICIPATED IN A 2-H HEALTH EDUCATION SESSION. THE PRIMARY OUTCOME OF THIS TRIAL WAS SYSTOLIC BLOOD PRESSURE AT 90-DAY FOLLOW-UP. DATA WERE ANALYSED ON AN INTENTION-TO-TREAT BASIS USING LINEAR MIXED-EFFECTS REGRESSION MODELS. RESULTS: WE INCLUDED ALL 121 STUDY PARTICIPANTS (INTERVENTION/CONTROL = 61/60) IN THE PRIMARY ANALYSIS (52.1% MALES; MEAN +/- SD AGE = 47.8 +/- 10.8 YEARS). THE DIFFERENCE IN SYSTOLIC BLOOD PRESSURE BETWEEN THE INTERVENTION GROUP AND THE CONTROL GROUP WAS - 7.66 MMHG (95% CI: - 10.4, - 4.93). FOR DIASTOLIC BLOOD PRESSURE, THE DIFFERENCE WAS - 3.86 MMHG (95% CI: - 6.65, - 1.06). NO ADVERSE EVENTS WERE REPORTED BY THE PARTICIPANTS. CONCLUSIONS: A YOGA PROGRAM FOR HYPERTENSIVE PATIENTS CONSISTING OF A FIVE-DAY TRAINING IN HEALTH CENTRES AND 90 DAYS OF PRACTICE AT HOME IS EFFECTIVE FOR REDUCING BLOOD PRESSURE. SIGNIFICANT BENEFITS FOR HYPERTENSIVE PATIENTS COULD BE EXPECTED IF SUCH PROGRAMMES WOULD BECOME A PART OF THE STANDARD TREATMENT PRACTICE. TRIAL REGISTRATION: THIS TRIAL WAS PROSPECTIVELY REGISTERED WITH THE CLINICAL TRIAL REGISTRY OF INDIA [ CTRI/2017/02/007822 ] ON 10/02/2017. 2021 20 2056 56 THE BENEFICIAL EFFECT OF YOGA IN DIABETES. TWENTY NIDDM SUBJECTS (MILD TO MODERATE DIABETICS) IN THE AGE GROUP OF 30-60 YEARS WERE SELECTED FROM THE OUT PATIENT CLINIC OF G.T.B. HOSPITAL. THEY WERE ON A 40 DAYS YOGA ASANA REGIME UNDER THE SUPERVISION OF A YOGA EXPERT. 13 SPECIFIC YOGA ASANAS < OR = DONE BY TYPE 2 DIABETES PATIENTS INCLUDED. SURYA NAMASKAR, TRIKONASANA, TADASANA, SUKHASANA, PADMASANA, BHASTRIKA PRANAYAMA, PASHIMOTTANASANA, ARDHMATSYENDRASANA, PAWANMUKTASANA, BHUJANGASANA, VAJRASANA, DHANURASANA AND SHAVASANA ARE BENEFICIAL FOR DIABETES MELLITUS. SERUM INSULIN, PLASMA FASTING AND ONE HOUR POSTPRANDIAL BLOOD GLUCOSE LEVELS AND ANTHROPOMETRIC PARAMETERS WERE MEASURED BEFORE AND AFTER YOGA ASANAS. THE RESULTS INDICATE THAT THERE WAS SIGNIFICANT DECREASE IN FASTING GLUCOSE LEVELS FROM BASAL 208.3 +/- 20.0 TO 171.7 +/- 19.5 MG/DL AND ONE HOUR POSTPRANDIAL BLOOD GLUCOSE LEVELS DECREASED FROM 295.3 +/- 22.0 TO 269.7 +/- 19.9 MG/DL. THE EXACT MECHANISM AS TO HOW THESE POSTURES AND CONTROLLED BREATHING INTERACT WITH SOMATOENDOCRINE MECHANISM AFFECTING INSULIN KINETICS WAS WORKED OUT. A SIGNIFICANT DECREASE IN WAIST-HIP RATIO AND CHANGES IN INSULIN LEVELS WERE ALSO OBSERVED, SUGGESTING A POSITIVE EFFECT OF YOGA ASANAS ON GLUCOSE UTILISATION AND FAT REDISTRIBUTION IN NIDDM. YOGA ASANAS MAY BE USED AS AN ADJUNCT WITH DIET AND DRUGS IN THE MANAGEMENT OF TYPE 2 DIABETES. 2005